Perrigo Price to Sales Ratio 2010-2024 | PRGO
Historical PS ratio values for Perrigo (PRGO) over the last 10 years. The current P/S ratio for Perrigo as of April 21, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Perrigo P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-04-21 | 24.36 | 0.77 | |
| 2024-12-31 | 25.45 | $31.83 | 0.80 |
| 2024-09-30 | 25.72 | $32.10 | 0.80 |
| 2024-06-30 | 24.94 | $32.40 | 0.77 |
| 2024-03-31 | 30.95 | $33.36 | 0.93 |
| 2023-12-31 | 30.63 | $34.25 | 0.89 |
| 2023-09-30 | 30.14 | $34.29 | 0.88 |
| 2023-06-30 | 31.78 | $34.26 | 0.93 |
| 2023-03-31 | 33.29 | $33.86 | 0.98 |
| 2022-12-31 | 31.41 | $33.11 | 0.95 |
| 2022-09-30 | 32.59 | $32.80 | 0.99 |
| 2022-06-30 | 36.82 | $32.42 | 1.14 |
| 2022-03-31 | 34.65 | $31.43 | 1.10 |
| 2021-12-31 | 34.81 | $30.91 | 1.13 |
| 2021-09-30 | 42.07 | $30.32 | 1.39 |
| 2021-06-30 | 40.52 | $29.81 | 1.36 |
| 2021-03-31 | 35.58 | $29.37 | 1.21 |
| 2020-12-31 | 39.09 | $29.76 | 1.31 |
| 2020-09-30 | 39.95 | $24.68 | 1.62 |
| 2020-06-30 | 47.89 | $26.10 | 1.83 |
| 2020-03-31 | 41.50 | $27.62 | 1.50 |
| 2019-12-31 | 44.41 | $28.35 | 1.57 |
| 2019-09-30 | 47.85 | $34.39 | 1.39 |
| 2019-06-30 | 40.58 | $33.93 | 1.20 |
| 2019-03-31 | 40.85 | $34.07 | 1.20 |
| 2018-12-31 | 32.74 | $34.05 | 0.96 |
| 2018-09-30 | 59.64 | $34.40 | 1.73 |
| 2018-06-30 | 61.26 | $34.85 | 1.76 |
| 2018-03-31 | 69.85 | $34.93 | 2.00 |
| 2017-12-31 | 72.88 | $34.64 | 2.10 |
| 2017-09-30 | 70.65 | $34.93 | 2.02 |
| 2017-06-30 | 62.90 | $35.05 | 1.79 |
| 2017-03-31 | 55.18 | $35.77 | 1.54 |
| 2016-12-31 | 69.02 | $36.86 | 1.87 |
| 2016-09-30 | 76.45 | $20.57 | 3.72 |
| 2016-06-30 | 74.95 | $20.43 | 3.67 |
| 2016-03-31 | 105.60 | $11.07 | 9.54 |
| 2015-12-31 | 119.30 | $8.53 | 13.98 |
| 2015-09-30 | 129.55 | $23.37 | 5.54 |
| 2015-06-30 | 152.15 | $21.78 | 6.98 |
| 2015-03-31 | 136.19 | $21.78 | 6.25 |
| 2014-12-31 | 137.41 | $22.39 | 6.14 |
| 2014-09-30 | 123.37 | $24.48 | 5.04 |
| 2014-06-30 | 119.65 | $27.25 | 4.39 |
| 2014-03-31 | 126.86 | $27.25 | 4.65 |
| 2013-12-31 | 125.79 | $29.51 | 4.26 |
| 2013-09-30 | 101.07 | $28.93 | 3.49 |
| 2013-06-30 | 99.04 | $27.24 | 3.64 |
| 2013-03-31 | 97.12 | $27.24 | 3.57 |
| 2012-12-31 | 85.02 | $25.77 | 3.30 |
| 2012-09-30 | 94.86 | $25.34 | 3.74 |
| 2012-06-30 | 96.23 | $24.90 | 3.86 |
| 2012-03-31 | 84.23 | $24.90 | 3.38 |
| 2011-12-31 | 79.27 | $24.02 | 3.30 |
| 2011-09-30 | 79.04 | $22.80 | 3.47 |
| 2011-06-30 | 71.47 | $21.95 | 3.26 |
| 2011-03-31 | 64.62 | $21.95 | 2.94 |
| 2010-12-31 | 51.42 | $20.37 | 2.52 |
| 2010-09-30 | 52.08 | $18.95 | 2.75 |
| 2010-06-30 | 47.85 | $17.73 | 2.70 |
| 2010-03-31 | 47.52 | $17.73 | 2.68 |
| 2009-12-31 | 32.19 | $17.35 | 1.86 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.455B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Medtronic (MDT) | Ireland | $105.938B | 15.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| ResMed (RMD) | United States | $31.269B | 24.08 |
| Agilent Technologies (A) | United States | $29.217B | 19.30 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Baxter (BAX) | United States | $14.818B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Haemonetics (HAE) | United States | $2.872B | 13.52 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Neogen (NEOG) | United States | $0.953B | 12.19 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.24 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.65 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |